valerianae radix
Botanicalexperimental
Clinical trial activity
7 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
1
Earliest trial started May 1, 1998 (NCT02183714)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108165 ↗
Also known as
- valerian
- valerian
- valerian
- valerian
- valeriana
- valeriana
- valerianae radix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05684523 | Phase 4 | Mar 1, 2023 | Max Zeller Soehne AG, University of Basel |
| NCT05185219 | N/A | Dec 14, 2021 | China Medical University |
| NCT06318052 | N/A | Nov 1, 2019 | Lumenis Be Ltd. |
| NCT00794456 | Phase 3 | Sep 1, 2009 | Marjan Industria e Comercio ltda |
| NCT02273453 | Phase 1 | Feb 1, 2003 | Boehringer Ingelheim |
| NCT00070928 | Phase 2 | Sep 1, 2000 | Emory University, National Center for Complementary and Integrative Health (NCCIH) |
| NCT02183714 | Phase 3 | May 1, 1998 | Boehringer Ingelheim |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 2 | 2 | 2 | 1998 |
| China Medical University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Emory University | Academic/Hospital | 1 | 0 | 1 | 2000 |
| Lumenis Be Ltd. | For profit | 1 | 1 | 1 | 2019 |
| Marjan Industria e Comercio ltda | For profit | 1 | 1 | 1 | 2009 |
| Max Zeller Soehne AG | For profit | 1 | 1 | 1 | 2023 |
| National Center for Complementary and Integrative Health (NCCIH) | Government | 1 | 1 | 1 | 2000 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2023 |
8 organizations
Page 1 / 1